When COVID-19 Fear Disrupts Asthma Care

June 4, 2020

Fear of COVID-19 is keeping allergy and asthma patients away from the doctor’s office. For the sake of their health, I’d like to set the record straight.

The Value of Ventilator Access

April 27, 2020

COVID-19 has made ventilator access a front-page issue. But for patients with chronic respiratory conditions, especially Medicare beneficiaries, the challenge is hardly a new one.

ICER Misses the Numbers That Matter

March 18, 2020

The Institute for Clinical and Economic Review wants to assess the cost-effectiveness of breakthrough drugs for cystic fibrosis. But their…

Asthma Patients’ Corticosteroid Conundrum

August 29, 2019

For someone with a flare-up of asthma symptoms, a short course of oral corticosteroids like prednisone can be a welcome relief. But when these potent medications become a regular remedy, asthma patients may have a problem.

Infants Aren’t the Only Ones Hurt by RSV

June 13, 2019

A seasonal respiratory virus that threatens the lives of infants also can have a ripple effect on caregivers, families and workplaces, a new data analysis demonstrates.

ICER’s Asthma Report Comes up Short

October 22, 2018

It’s plagued by incomplete analysis and missing data, yet the Institute for Clinical and Economic Review’s draft evidence report on severe asthma medicine still manages to deliver a familiar refrain.  All five of the drugs reviewed, ICER reports, are not cost-effective.